These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2380110)

  • 21. A54145, a new lipopeptide antibiotic complex: isolation and characterization.
    Fukuda DS; Du Bus RH; Baker PJ; Berry DM; Mynderse JS
    J Antibiot (Tokyo); 1990 Jun; 43(6):594-600. PubMed ID: 2380107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro activity of roxithromycin against hospital bacteria and the concordance curve].
    Soussy CJ; Chanal M; Kitzis MD; Duval J; Cluzel R; Acar JF
    Pathol Biol (Paris); 1988 May; 36(5):420-4. PubMed ID: 2900488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo antibacterial activity of cefodizime, a new cephalosporin antibiotic.
    Kasai K; Tsuji A; Miyazaki S; Goto S; Fujimoto K; Masuyoshi S; Arai S
    Jpn J Antibiot; 1984 Jul; 37(7):1306-12. PubMed ID: 6092740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental studies and clinical experieces with linocomycin].
    Meyer-Rohn J
    Hautarzt; 1968 Nov; 19(11):505-9. PubMed ID: 4303409
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus.
    Lepak AJ; Seiler P; Surivet JP; Ritz D; Kohl C; Andes DR
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3626-32. PubMed ID: 27044547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The changing character of infective endocarditis.
    Quinn EL; Burch KH; Cox F; Fisher E; Madhavan T
    Am Fam Physician; 1975 Mar; 11(3):117-24. PubMed ID: 803764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Shufeng Jiedu capsules as a broad-spectrum antibacterial.
    Bao Y; Gao Y; Cui X
    Biosci Trends; 2016 Feb; 10(1):74-8. PubMed ID: 26875500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of the automated system for bacteriological diagnosis of suppurative complications].
    Imshenetskaia VF
    Antibiot Khimioter; 1990 Oct; 35(10):41-3. PubMed ID: 2278498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug sensitivity of bacterial strains isolated from clinical specimens during the years 1987-1988].
    Rafałowska K; Leszczyński P
    Pol Tyg Lek; 1990 Sep 3-10; 45(36-37):732-5. PubMed ID: 2084629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maridomycin, a new macrolide antibiotic: in vivo antibacterial activity of 9-propionylmaridomycin.
    Kondo M; Ishifuji K; Tsuchiya K; Goto S; Kuwahara S
    Antimicrob Agents Chemother; 1973 Aug; 4(2):156-9. PubMed ID: 4790936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coumamidines, new broad spectrum antibiotics of the cinodine type. III. Microbiologic activity of coumamidine gamma 1.
    Fernandes PB; Swanson RN; Hardy DJ; Hanson CW; McDaniel D; Beyer J; Chen RH
    J Antibiot (Tokyo); 1989 Apr; 42(4):538-41. PubMed ID: 2498268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enduracidin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity.
    Tsuchiya K; Kondo M; Oishi T; Yamazaki I
    J Antibiot (Tokyo); 1968 Feb; 21(2):147-53. PubMed ID: 4386300
    [No Abstract]   [Full Text] [Related]  

  • 34. Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Kamimura T; Tawara S; Matsumoto Y; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1993 Jan; 46(1):99-119. PubMed ID: 8436564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alfa-6-deoxy-oxy-tetracycline in the treatment of pyogenic infections of skin.
    Chuttani CS; Saxena SN; Pal SC; Chuttani HK
    Chemotherapy; 1969; 14(2):101-8. PubMed ID: 5807483
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of the in vitro activity of tigecycline against multiresistant Gram-positive cocci containing tetracycline resistance determinants.
    Borbone S; Lupo A; Mezzatesta ML; Campanile F; Santagati M; Stefani S
    Int J Antimicrob Agents; 2008 Mar; 31(3):209-15. PubMed ID: 17646087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A54145, a new lipopeptide antibiotic complex: discovery, taxonomy, fermentation and HPLC.
    Boeck LD; Papiska HR; Wetzel RW; Mynderse JS; Fukuda DS; Mertz FP; Berry DM
    J Antibiot (Tokyo); 1990 Jun; 43(6):587-93. PubMed ID: 2380106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A40926 aglycone and pseudoaglycones: preparation and biological activity.
    Selva E; Goldstein BP; Ferrari P; Pallanza R; Riva E; Berti M; Borghi A; Beretta G; Scotti R; Romanò G
    J Antibiot (Tokyo); 1988 Sep; 41(9):1243-52. PubMed ID: 3053550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotics: the race continues].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2012 Sep; 35(9):311. PubMed ID: 23050347
    [No Abstract]   [Full Text] [Related]  

  • 40. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.